| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SKYE | Common Stock | Award | +1,406,543 | +47% | 4,406,543 | 10 Nov 2022 | Direct | F1 | ||
| transaction | SKYE | Common Stock | Award | +2,335,721 | 2,335,721 | 10 Nov 2022 | Trust | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SKYE | Stock Option (Right to Buy) | Award | +390,000 | 390,000 | 10 Nov 2022 | Common Stock | 390,000 | $1.60 | Direct | F3, F4 | |||
| transaction | SKYE | Stock Option (Right to Buy) | Award | +390,000 | 390,000 | 10 Nov 2022 | Common Stock | 390,000 | $0.1100 | Direct | F3, F5 | |||
| transaction | SKYE | Stock Option (Right to Buy) | Award | +487,500 | 487,500 | 10 Nov 2022 | Common Stock | 487,500 | $0.0600 | Direct | F3, F4 | |||
| transaction | SKYE | Stock Option (Right to Buy) | Award | +292,500 | 292,500 | 10 Nov 2022 | Common Stock | 292,500 | $0.0800 | Direct | F3, F6 |
| Id | Content |
|---|---|
| F1 | The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the "Arrangement Agreement"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the "Exchange Ratio"). |
| F2 | The shares are held by a trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares. |
| F3 | The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio. |
| F4 | The options underlying this award are fully vested. |
| F5 | Options will vest, or have vested, in equal installments on each of February 6, 2020, February 6, 2021, February 6, 2022, February 6, 2023. |
| F6 | 8.33% of the options vested on the grant date of August 3, 2020. An additional 8.333% of the options vest on each monthly anniversary of the grant date. |